BioSpace News Archive

For over 43 years, Alexandria Eye Clinic has served the region as a leader in primary and surgical eye care. On September 3, 2018, Alexandria Eye Clinic will become part of the Vance Thompson Vision family of clinics.

Airbus Perlan Mission II, the world’s first initiative to pilot an engineless aircraft to the edge of space, made history again yesterday in El Calafate, Argentina, by soaring in the stratosphere to a pressure altitude of over 62,000 feet (60,669 feet GPS altitude).

Eli Lilly and Company (NYSE:LLY) will attend the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018. Joshua Smiley, senior vice president and Lilly’s chief financial officer, will participate in a fireside chat at 1:40 p.m., Eastern Time.

Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 - 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level.

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

he Arizona Bioindustry Association (AZBio) today announced that on October 3, 2018, Arizona’s Life Science and Business Community will come together to honor Dr. Daniel D. Von Hoff with the Arizona Bioscience Pioneer Award for Lifetime Achievement at the AZBio Awards and Life Science Fiesta.

The Ministry of Health and Prevention (MOHAP) revealed that its ‘Junior Chef’ initiative successful completed its second phase on a high note—receiving overwhelming public response for its efforts to promote health awareness among children.

Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, focused on delivering first-in-class biological therapies that have the potential to transform the lives of people with serious diseases, today announces that it has dosed the first patient in a Phase I study, part of an ongoing collaboration with GlaxoSmithKline (GSK).

ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, today announced that the US Food and Drug Administration (FDA) has granted ASLAN003 Orphan Drug Designation (ODD) as a treatment for acute myeloid leukaemia (AML).

Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present at the following investor conferences: